Advanced non-melanoma skin cancers of the head and neck: An overview on management

Cancer Forum

Volumn 30, Issue 3, 2006, Pages 195-201

  Veness, Michael J ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; ETRETIN; IMMUNOSUPPRESSIVE AGENT; PLATINUM DERIVATIVE; RAPAMYCIN; RETINOID;

BASAL CELL CARCINOMA; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL FEATURE; CLINICAL TRIAL; HEAD AND NECK CANCER; HEADACHE; HUMAN; IMMUNE DEFICIENCY; LYMPH NODE METASTASIS; MERKEL CELL TUMOR; MULTIMODALITY CANCER THERAPY; ORGAN TRANSPLANTATION; PALLIATIVE THERAPY; PREVALENCE; REVIEW; SKIN CANCER; SKIN MANIFESTATION; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

EID: 33751365789     PISSN: 0311306X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Ramirez CC, Federman DG, Kirsner RS. Skin cancer as an occupational disease: the effect of ultraviolet and other forms of radiation. Int J Dermatol. 2005;44:95-100.
2. de Vries E, de Poll-Franse LV, Louwman WJ, de Gruijl FR, Coebergh JWW. Predictions of skin cancer incidence in the Netherlands up to 2015. Brit J Dermatol. 2005;152:481-488.
3. Staples MP, Elwood M, Burton RC, Williams JL, Marks R, Giles GG. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust. 2006;184:6-10.
4. Buettner PG, Raasch BA. Incidence rates of skin cancer in Townsville, Australia. Int J Cancer. 1998;78:587-593.
5. Joseph MG, Zulueta WP, Kennedy PJ. Squamous cell carcinoma of the skin. The incidence of metastases and their outcome. ANZ J Surg. 1991;62:697-701.
6. Czarnecki D, Staples M, Mar A, Giles G, Meehan C. Metastases from squamous cell carcinoma of the skin in Southern Australia. Dermatol. 1994;189:52-54.
7. Clayman GL, Lee JJ, Holsinger C, et al. Mortality risk from squamous cell skin cancer. J Clin Oncol. 2005;23:759-765.
8. Nolan RC, Chan MTL, Heenan PJ. A clinicopathologic review of lethal nonmelanoma skin cancers in Western Australia. J Am Acad Dermatol. 2005;52:101-108.
9. Cherpelis BS, Marcusen C, Lang PG. Prognostic factors for metastasis in squamous cell carcinoma of the skin. Dermatol Surg. 2002;28:268-273.
10. Veness MJ. Defining patients with high-risk cutaneous squamous cell carcinoma. Australas J Dermatol. 2006;47:28-33.
11. Nolan RC, Chan MTL, Heenan PJ. A clinicopathologic review of lethal nonmelanoma skin cancers in Western Australia. J Am Acad Dermatol. 2005;52:101-108.
12. Veness MJ, Morgan GJ, Palme C, Gebski V. Cutaneous head and neck squamous cell carcinoma metastatic to cervical lymph nodes: Surgery and adjuvant radiotherapy should be considered best practice. Laryngoscope. 2005;44:870-875.
13. Audet N, Palme CE, Gullane PJ, et al. Cutaneous metastatic squamous cell carcinoma to the parotid gland: analysis and outcome. Head Neck. 2004;26:727-732.
14. LH Sobin. TNM classification of malignant tumours. 6th ed. New York: Wiley and Sons; 2002.
15. Rodolico V, Barresi E, Di Lorenzo R et al. Lymph node metastasis in lower lip squamous cell carcinoma in relation to tumour size, histologic variables and p27kip1 protein expression. Oral Oncol. 2004;40:92-98.
16. Breuninger H, Schaumburg-Lever G, Holzschuh J, Horny HP. Desmoplastic squamous cell carcinoma of skin and vermilion surface. Cancer. 1997;79:915-919.
17. Rowe DE, Carroll RJ, Day CD. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear and lip. J Am Acad Dermatol. 1992;26:976-990.
18. Veness MJ, Palme C, Morgan GJ. Metastatic cutaneous squamous cell carcinoma of the head and neck: Results of 266 patients with metastatic SCC. Cancer. 2006;106:2389-2396.
19. Grover R, Douglas RG, Shaw HFS. Carcinoma of the lip in Auckland, New Zealand, 1969-1987. Head Neck. 1989;11:264-268.
20. Brueuninger H, Black B, Rassner G. Brief scientific statement: Microstaging of squamous cell carcinomas. Am J Clin Path. 1990;94:624-627.
21. Petter G, Haustein UF. Histologic subtyping and malignancy assessment of cutaneous squamous cell carcinoma. Dermatol Surg. 2000;26:521-530.
22. Moore BA, Weber RS, Prieto V, El-Naggar A, Holsinger FC, Zhou X, Lee JJ, Lippman S, Clayman GL. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Laryngoscope. 2005;115:1561-1567.
23. Leibovitch I, Huilgol SC, Selva D, Hill D, Richards S, Paver R. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I. Experience over 10 years. J Am Acad Dermatol. 2005;53:253-260.
24. Veness MJ. Treatment recommendations for patients diagnosed with high-risk cutaneous SCC. Australas Radiol. 2005;49:365-376.
25. Huang CC, Boyce SM. Surgical margins of excision for basal cell carcinoma and squamous cell carcinoma. Sem Cutan Med Surg. 2004;23:163-173.
26. de Visscher JG, Gooris PJJ, Vermey A, Roodenburg JLN. Surgical margins for resection of squamous cell carcinoma of the lower lip. Int J Oral Maxillofac Surg. 2002;31:154-157.
27. Babington S, Veness MJ, Cakir B, Gebski VJ, Morgan GJ. Squamous cell carcinoma of the lip: Is there a role for adjuvant radiotherapy in improving local control following incomplete or inadequate excision? ANZ J Surg. 2003;73:621-625.
28. Brodland DG, Zitelli JA. Surgical margins for excision of primary cutaneous squamous cell carcinoma. J Am Acad Dermatol. 1992;27:241-248.
29. Thomas DJ, King AR, Peat BG. Excision margins for nonmelanotic skin cancer. Plast Reconstr Surg. 2003;112:57-63.
30. Reschly MJ, Messina JL, Zaulyanov LL, Cruse W, Fenske NA. Utility of sentinel lymphadenectomy in the management of patients with high-risk cutaneous squamous cell carcinoma. Dermatol Surg. 2003;29:135-140.
31. Wagner JD, Evdokimow DZ, Weisberger E et al. Sentinel node biopsy for high-risk nonmelanoma cutaneous malignancy. Arch Dermatol. 2004;140:75-79.
32. Kwan W, Wilson D, Moravan M. Radiotherapy for locally advanced basal cell and squamous cell carcinoma of the skin. Int J Radiation Oncology Biol Phys. 2004;60:406-411.
33. Warner GC, Gandhi M, Panizza B. Slowly progressive cranial nerve palsies. Med J Aust. 2006;184:641-643.
34. Esmaeli B, Ahmadi MA, Gillenwater AM, Faustina MM, Amato M. The role of supraorbital nerve biopsy in cutaneous malignancies of the periocular region. Ophthal Plast Reconstr Surg. 2003;19:282-286.
35. Veness MJ, Biankin S. Perineural spread leading to orbital invasion from skin cancer. Australas Radiol. 2000;44:296-302.
36. Stasko T, Brown MD, Carucci JA, et al. Guidelines for the management of squamous cell carcinoma in organ transplant recipients. Dermatol Surg. 2004;30:642-650.
37. Smith KJ, Hamza S, Skelton H. Histological features in primary cutaneous squamous cell carcinomas in immunocompromised patients focusing on organ transplant patients. Dermatol Surg. 2004;30:634-641.
38. Martinez JC, Clark CO, Stasko T, Euvard S, Brown C, Schanbacher CF, Weaver AL. Defining the clinical course of metatstatic skin cancer in organ transplant recipients. Arch Dermatol. 2003;139:301-306.
39. Otley CC, Berg D, Ulrich C, et al. Reduction of immunosuppression for transplant-associated skin cancer: expert consensus survey. Br J Dermatol. 2006;124:395-400.
40. Kauffman HM, Cherikh WS, Cheng Y, et al. Maintenance immunosuppression with mTOR inhibitors is associated with a reduced incidence of de novo malignancies. Transplantation. 2005;80:883-889.
41. Chen K, Craig JC, Shumack S. Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomized controlled trials. Br J Dermatol. 2005;152:518-523.
42. Talmi YP, Horowitz Z, Wolf M, Kronenberg J. Delayed metastases in skin cancer of the head and neck: The case of the "known primary". Ann Plast Surg. 1999;42:289-292.
43. Dona E, Veness MJ, Cakir B, Morgan GJ. Metastatic cutaneous squamous cell carcinoma to the parotid: The role of surgery and adjuvant radiotherapy to achieve best outcome. ANZ J Surg. 2003;73:692-696.
44. Veness MJ, Palme CE, Smith M, Cakir B, Morgan GJ, Kalnins I. Cutaneous head and neck squamous cell carcinoma metastatic to cervical lymph nodes (nonparotid): a better outcome with surgery and adjuvant radiotherapy. Laryngoscope. 2003;113:1827-1833.
45. Jol JAD, van Velthuysen MLF, Hilgers FJM, Keus RB, Neering H, Balm AJM. Treatment results of regional metastasis from cutaneous head and Neck squamous cell carcinoma. EJSO. 2002;29:81-86.
46. Campbell B, Rischin D, Corry J, et al. Post-operative chemo-therapy for high-risk head and neck squamous cell carcinoma (HNSCC). 12th International Congress of Radiation Research, Brisbane, Australia 2003 (Abstract) PP07/0267 p97.
47. O'Brien CJ, McNeil EB, McMahon JD, Pathak I, Lauer CS, Jackson MA. Significance of clinical stage, extent of surgery and pathological findings in metastatic cutaneous squamous carcinoma of the parotid gland. Head Neck. 2002;24:417-422.
48. Andruchow JL, Veness MJ, Morgan GJ, et al. Implications for clinical staging of metastatic cutaneous SCC of the head and neck based on a multicentre study of treatment outcomes. Cancer. 2006;106:1078-1083.
49. Goessling W, McKee PH, Mayer RJ. Merkel cell carcinoma. J Clin Oncol. 2002;20:588-598.
50. Tai PT, Yu E, Winquist E, Hammond A, Stitt L, Tonita J, Gilchrist J. Chemotherapy in neuro-endocrine/Merkel cell carcinoma of the skin: Case series and review of 204 cases. J Clin Oncol. 2000;18:2493-9.
51. Poulsen M. Merkel-cell carcinoma of the skin. Lancet Oncol. 2005;5:593-599.
52. Medina-Franco H, Urist MM, Fiveash J, Heslin MJ, Bland KI, Beenken SW. Multimodality treatment of Merkel cell carcinoma: Case series and literature review of 1024 cases. Ann Surg Oncol. 2001;8:204-208.
53. Poulsen M, Harvey J. Is there a diminishing role for surgery for Merkel cell carcinoma of the skin? A review of current management. ANZ J Surg. 2002;72:142-146.
54. Veness MJ, Perera L, McCourt J, Shannon J, Hughes M, Morgan GJ, Gebski V. Merkel cell carcinoma: Improved regional control and survival with adjuvant radiotherapy. ANZ J Surg. 2005;75:275-281.
55. Gupta SG, Wang LC, Penas PF, Gellenthin M, Lee SJ, Nghiem P. Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma. Arch Dermatol. 2006;142:685-690.
56. Mortier L, Mirabel X, Fournier C, Piette F, Lartigau. Radiotherapy alone for primary Merkel cell carcinoma. Arch. Dermatol. 2003;139:1587-1590.
57. Lewis KG, Weinstock MA, Weaver AL, Otley CC. Adjuvant local irradiation for Merkel cell carcinoma. Arch Dermatol. 2006;142:693-700.
58. Poulsen M, Rischin D, Walpole E, Harvey J, Mackintosh J, Ainslie J, Hamilton C, Keller J, Tripcony L. High risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: A Trans-Tasman Radiation Oncology Group study - TROG 96:07. J Clin Oncol. 2003;21:4371-4376.
59. Poulsen MG, Rischin D, Porter I, Walpole E, Harvey J, Hamilton C, Keller J, Tripcony L. Does chemotherapy improve survival in high-risk stage I and II merkel cell carcinoma of the skin? Int J Radiat Oncol Biol Phys. 2006;64:114-119.
60. Eng TY, Naguib M, Fuller CD, Jones WE, Herman TS. Treatment of recurrent Merkel cell carcinoma: An analysis of 46 cases. Am J Clin Oncol. 2004;24:576-583.
61. Veness MJ, Richards S. Role of modern radiotherapy in treating skin cancer. Australas J Dermatol. 2003;44:159-168.
62. Wilson AW, Howsam G, Santhanam V, Macpherson D, Grant J, CA, Townend JV. Surgical management of incompletely excised basal cell carcinomas of the head and neck. Br J Oral Maxillofacial Surg. 2004;42:311-314.